Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 15;10(12):3260.
doi: 10.3390/biomedicines10123260.

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis

Affiliations

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis

Anke K Jaekel et al. Biomedicines. .

Abstract

Neurogenic lower urinary tract dysfunction (NLUTD) in asymptomatic patients with MS has been described in preliminary studies, but specific investigations of this topic are rare. Many authors advise early diagnosis and treatment of NLUTD in patients with MS. In contrast, clinical practice and different guidelines recommend neuro-urological diagnostics only in the presence of symptoms. Our aim was to investigate the characteristics of NLUTD and the correlations of clinical parameters with NLUTD in asymptomatic patients with MS. We evaluated bladder diaries, urodynamic findings, and therapy proposals. Correlations of the voided volume, voiding frequency, urinary tract infections, and uroflowmetry including post-void residual with the urodynamic findings were determined. In our study, 26% of the patients were asymptomatic. Of these, 73.7% had urodynamic findings indicative of NLUTD, 21.1% had detrusor overactivity, 13.2% had detrusor underactivity, 13.2% detrusor overactivity and detrusor sphincter dyssynergia, and 57.9% had radiologically abnormal findings of the bladder. No patients presented low bladder compliance or renal reflux. Clinical parameters from the bladder diary and urinary tract infections were found to be correlated with NLUTD, and the absence of symptoms did not exclude NLUTD in patients with MS. We observed that urinary tract damage is already present in a relevant proportion. Based on our results, we recommend that patients with MS be screened for NLUTD regardless of the subjective presence of urinary symptoms or the disease stage.

Keywords: bladder diary (BD); multiple sclerosis (MS); neuro-urology; neurogenic lower urinary tract dysfunction (NLUTD); post-void residual (PVR); upper urinary tract damage (UUTD); urodynamic study (UDS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Aharony S.M., Lam O., Corcos J. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines. Can. Urol. Assoc. J. 2017;11:61–64. doi: 10.5489/cuaj.4058. - DOI - PMC - PubMed
    1. Giannantoni A., Scivoletto G., Di Stasi S.M., Grasso M.G., Agrò E.F., Collura G., Vespasiani G. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch. Phys. Med. Rehabil. 1999;80:437–441. doi: 10.1016/S0003-9993(99)90282-4. - DOI - PubMed
    1. Ineichen B.V., Schneider M.P., Hlavica M., Hagenbuch N., Linnebank M., Kessler T.M. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis. Mult. Scler. 2018;24:529–534. doi: 10.1177/1352458517703801. - DOI - PubMed
    1. Averbeck M.A., Iacovelli V., Panicker J., Schurch B., Finazzi Agrò E. Urodynamics in patients with multiple sclerosis: A consensus statement from a urodynamic experts working group. Neurourol. Urodyn. 2020;39:73–82. doi: 10.1002/nau.24230. - DOI - PubMed
    1. Amarenco G., Chartier-Kastler E., Denys P., Jean J.L., de Sèze M., Lubetzski C. First-line urological evaluation in multiple sclerosis: Validation of a specific decision-making algorithm. Mult. Scler. 2013;19:1931–1937. doi: 10.1177/1352458513489758. - DOI - PubMed